The use of infliximab in South-east Asian children with severe Crohn's disease

Pediatrics International

Volumn 46, Issue 2, 2004, Pages 198-201

  Lee, Way Seah ^a  

^a UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

Author keywords

Crohn's disease; Infliximab; Perianal disease

Indexed keywords

AZATHIOPRINE; HYDROCORTISONE; INFLIXIMAB; MESALAZINE; METRONIDAZOLE; PREDNISOLONE; STEROID;

ANAMNESIS; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CHILD; CLINICAL FEATURE; CROHN DISEASE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; FEMALE; HUMAN; LEIOMYOSARCOMA; MALE; PRIORITY JOURNAL; SIDE EFFECT; SOUTHEAST ASIA; SYMPTOM; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ASIA, SOUTHEASTERN; CHILD; CHILD, PRESCHOOL; CROHN DISEASE; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; MALE;

EID: 1942422123     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-200x.2004.01870.x     Document Type: Article

References (10)

1. Griffiths AM, Buller HB. Inflammatory bowel disease. In. Walker WA, Durie PR, Hamilton JR et al. (eds) Pediatric Gastrointestinal Disease: Pathophysiology, diagnosis, management. 3rd edn. BC Decker, Ontario, Canada, 2000.
2. Beese E, Michie C, Nicholls S et al. Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 1994; 106: 1455-66.
3. Hyams JS, Markowitz J, Wyllie R. Use of infliximab in the treatment of Crohn's disease in children and adolescents. J. Pediatr. 2000; 137: 192-6.
4. Hyams JS, Ferry GD, Mandel FS et al. Development and validation of a pediatric Crohn's disease activity index. J. Pediatr. Gastroenterol. Nutri. 1991; 12: 439-47.
5. Ti TK. Inflammatory disease of the bowel: a Malaysian experience. Aust. N. Z. J. Surg. 1979; 49: 428-31.
6. Lee YM, Fock K, See SJ, Ng TM, Khor C, Teo EK. Racial difference in the prevalence of ulcerative colitis and Crohn's disease in Singapore. J. Gastroenterol. Hepatol. 2000; 15: 622-5.
7. Hanauer SB, Feagan BG, Lichtenstein GR et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomized trial. Lancet 2002; 359: 1541-9.
8. Persley K, Scherl E, Rubin P. Avoidance of steroids by the early use of infliximab and 6-Mercaptopurine in an adolescent with active Crohn's colitis. Am. J. Gastroenterol. 2001; 96: 3444-5.
9. Mir-Madjlessi SH, Farmer RG, Easley KA et al. Colorectal and extracolonic malignancy in ulcerative colitis. Cancer 1986; 58: 1569-74.
10. Arseneau KO, Stukenborg GJ, Connors AF Jr, Cominelli F. The incidence of lymphoid and myeloid malignancies among hospitalized Crohn's disease patients. Inflamm. Bowel Dis. 2001; 7: 106-12.